FDA Requires Black Box Warnings for Bowel Cleansers Visicol and OsmoPrep

On November 11, 2008 the Food and Drug Commission issued an alert about the safe use of bowel cleansing products that contain oral sodium phosphate. The FDA is requiring that the manufacturers of prescription Visicol® and OsmoPrep® put Black Box warnings on the labels for these products.  In addition, the FDA intends to change labeling for…  Read More